Navigation Links
Ingenuity's Technology Powers BD Cell Pathways Tool on New BD Biosciences Website
Date:8/11/2009

REDWOOD CITY, Calif., Aug. 11 /PRNewswire/ -- Ingenuity Systems today announced that BD Biosciences, a segment of BD (Becton, Dickinson and Company), is integrating Ingenuity's Knowledge Base and its Search and Pathway Navigation technologies into its new website. By leveraging Ingenuity's biological pathways and molecular networks, BD Biosciences will enable its research customers to quickly and easily identify products and experimental design options most relevant to their research.

From the free, user-friendly search application on the BD Biosciences homepage, researchers can search for genes, proteins, pathways, and more, and then explore related pathways and networks to easily identify BD products of interest. In addition to identifying products, researchers can also quickly understand alternative product and experimental design options by exploring gene pathways and molecular interaction networks - including a molecule's role in diseases, biological processes, functions, and tissues - all based on knowledge from the scientific literature.

"The BD Cell Pathways tool, powered by Ingenuity Systems, offers a unique opportunity for our customers to identify BD products in the context of comprehensive and dynamic biological systems," said Andy Last, Vice President, Global Marketing and Strategic Planning, BD Biosciences. "We are pleased to offer the Ingenuity technology to empower customer research with high-quality information."

Jake Leschly, CEO of Ingenuity, commented, "Through the BD Biosciences website, researchers can now use Ingenuity's interactive, up-to-date pathways and network diagrams to visualize and explore the interaction of genes and gene products. By understanding the broader biological context, researchers can optimize experimental design and quickly identify the most relevant products for their research."

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. Our long-term focus on innovation in semantic search has allowed us to create groundbreaking technologies that have one common goal -- to generate maximum value from all types of biological and chemical knowledge. Ingenuity offerings leverage the Ingenuity Knowledge Base, which contains uniquely structured literature findings that allow scientists to ask complex biological questions and gain rapid insight into their experimental data or systems of interest. Today, Ingenuity's solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, academic, and government research institutions worldwide. For more information visit: www.ingenuity.com


'/>"/>
SOURCE Ingenuity Systems
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017 Patients are the most ... CSL Behring awards Local Empowerment for Advocacy Development (LEAD) ... groups. These groups tackle complex legislative and public policy ... Hill and in statehouses across the U.S. ... was awarded to New England Hemophilia Association (NEHA), Neuropathy ...
(Date:3/29/2017)... /PRNewswire/ - Last year,s petition to the White House signed ... active to generate awareness on the importance of new organic medicines ... healthcare market place. ... Earlier this month Health Advance (OTC PINK: ... nutritional products, announced its endeavors on this generally recognized as ...
(Date:3/29/2017)... ... March 29, 2017 , ... ComplianceOnline, the leading governance, risk ... its 3rd Annual Medical Device Summit 2017 venue and speaker lineup. The Summit will ... in Boston, MA. , The Omni Parker House Hotel, which is located at 60 ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... edge instrumentation for cell-based assays, disperses a quarterly travel award to noteworthy scientists ... Today the company announced that its new round of awards are being given ...
Breaking Biology Technology:
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... and Reentry. "Too often, too many ... and county jails are trying to tackle this ... and friends and family members. While significant steps are ...
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
Breaking Biology News(10 mins):